Taiwan Biomaterial Co., Ltd.

Taiwan Biomaterial Co., Ltd. develops and sells implantable medical devices in Taiwan. Its products include Foamagen, a dura substitute; a negative-pressure catheter system for removing stroke-related blood clots from cerebral vessels, along with a nickel-titanium guidewire for cerebral vascular surgery; and tissue repair and regeneration products for treating early osteoarthritis. The company also provides CDMO services. It was founded in 1921 and is based in Zhubei, Taiwan.